Posts

Track 12: Cancer Metastasis – Advancing Research, Diagnosis, and Therapeutic Innovation

Image
  The 13th International Cancer and Medical Oncology Conference and Exhibition will spotlight one of the most critical and challenging areas in oncology through Track 12: Cancer Metastasis . This specialized track will bring together leading oncologists, cancer researchers, molecular biologists, clinicians, surgeons, pharmaceutical experts, and healthcare innovators to discuss the latest breakthroughs in metastatic cancer research, precision therapies, tumor progression mechanisms, and translational oncology. Hosted during the prestigious 13th International Cancer and Medical Oncology Conference and Exhibition at Novotel Al Barsha Dubai in Dubai, this global oncology gathering is expected to attract researchers and healthcare professionals from across the world. Understanding Cancer Metastasis Cancer metastasis is the process through which cancer cells spread from the primary tumor site to distant organs and tissues. It remains the leading cause of cancer-related mortality world...

Track 11: Tumor Microenvironment – Transforming the Future of Cancer Therapy

Image
  The Tumor Microenvironment (TME) has emerged as one of the most critical areas in modern oncology research. At the 13th International Cancer and Medical Oncology Conference and Exhibition , Track 11: Tumor Microenvironment will spotlight groundbreaking discoveries, translational research, and innovative therapeutic strategies that are reshaping cancer diagnosis and treatment. Scheduled for February 1–2, 2027, at Novotel Al Barsha, this prestigious global event will unite oncologists, researchers, immunologists, pathologists, clinicians, biotech innovators, and healthcare professionals from around the world to discuss the evolving role of the tumor microenvironment in cancer progression and precision medicine. Understanding the Tumor Microenvironment The tumor microenvironment refers to the complex ecosystem surrounding tumor cells, including immune cells, blood vessels, fibroblasts, extracellular matrix components, signaling molecules, and inflammatory mediators. Rather than e...

Track 10: Cancer Epigenetics 13th International Cancer and Medical Oncology Conference and Exhibition

Image
  Track 10: Cancer Epigenetics 13th International Cancer and Medical Oncology Conference and Exhibition February 1–2, 2027 | Novotel Al Barsha, Dubai, UAE The 13th International Cancer and Medical Oncology Conference and Exhibition will bring together oncologists, cancer researchers, molecular biologists, clinicians, healthcare innovators, academicians, and industry experts from across the globe to discuss the latest advancements in oncology research and clinical care. One of the highly anticipated sessions of the conference is Track 10: Cancer Epigenetics , focusing on the rapidly evolving role of epigenetic mechanisms in cancer development, diagnosis, and treatment. Cancer epigenetics has emerged as a transformative area in oncology, offering groundbreaking insights into how gene expression changes influence tumor initiation and progression without altering the DNA sequence itself. This track will highlight innovative research in DNA methylation, histone modification, chromatin r...